Business Context and Reporting Period
This is an Amendment No. 1 to a Form 8-K filed by Clarivate Plc on May 14, 2020. The filing amends a previous report dated March 2, 2020, regarding the completion of the acquisition of Decision Resources Group (DRG) on February 28, 2020. DRG is a provider of data, analytics, and insights for the healthcare industry. The primary purpose of this amendment is to provide the financial statements and pro forma financial information required by SEC rules, which were not included in the original filing.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Instead, it references the following documents filed as exhibits which contain the data:
- Exhibit 99.1: Audited combined financial statements of DRG for the year ended December 31, 2019.
- Exhibit 99.2: Unaudited pro forma condensed combined statements of operations for the year ended December 31, 2019, and the three months ended March 31, 2020, giving effect to the DRG acquisition.
Material Changes
The material change reported is the formal inclusion of financial data related to the acquisition of DRG. The acquisition was first announced on January 17, 2020, and completed on February 28, 2020. This amendment ensures compliance with Item 9.01 of Form 8-K by supplying the previously omitted financial statements and pro forma information.
Guidance, Outlook, and Risks
The filing text does not contain specific management commentary, forward-looking guidance, risk factors, or details on contingencies beyond the procedural requirement to file the acquisition's financial data. The document focuses strictly on the regulatory compliance aspect of the asset acquisition.
Investor Verification Checklist
- Review Exhibit 99.1 for DRG's standalone audited financial performance for 2019.
- Analyze Exhibit 99.2 to understand the pro forma impact of the DRG acquisition on Clarivate's operations for 2019 and Q1 2020.
- Verify the integration timeline and any potential synergies or costs associated with the DRG acquisition in subsequent earnings reports.
- Confirm the treatment of goodwill and intangible assets resulting from the acquisition in the pro forma statements.